Caprolactam Chemicals Ltd — Board Meeting, 30-05-2025: Board Meeting

Caprolactam Chemicals Ltd. has announced a board meeting outcome approving the audited financial results for the quarter and financial year ended 31 March 2025. The company reported a decline in total income to ₹674.92 lakh for the year compared to ₹713.71 lakh the previous year. Expenses rose to ₹743.29 lakh from ₹686.47 lakh, leading to a loss before tax of ₹68.37 lakh, against a profit of ₹27.24 lakh earlier. After tax, the company recorded a net loss of ₹70.87 lakh for the year, compared to a net profit previously. Earnings per share fell to a loss of ₹1.54. Total assets increased to ₹1,428.42 lakh, primarily funded by higher short-term borrowings at ₹871.34 lakh, impacting liquidity and financial health. The statutory auditor issued an unmodified opinion on the results, indicating confidence in the financial statements. This performance signals operational and financial challenges, likely to be closely monitored by shareholders.